International Clinical Trial: 3D-MRE-based DLR model to predict status of intratumoral tertiary lymphoid structures in HCC and evaluate biological mechanisms

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118431) titled '3D-MRE-based DLR model to predict status of intratumoral tertiary lymphoid structures in HCC and evaluate biological mechanisms' on Feb. 5.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Xiangya Hospital Central South University

Condition: Hepatocellular Carcinoma

Intervention: Gold Standard:The TLS pathological indicators were analyzed by a pathologist with more than 10 years of liver pathology experience, who was unaware of other clinical and imaging information. TLS: a. Aggregates: fuzzy and unclear lymphocyte clusters b. Primary follicles: circular lymphocyte cl...